[1] Schuppan D. Liver fibrosis: Common mechanisms and antifibrotic therapies. Clin Res Hepatol Gastroenterol, 2015, 39: S51-S59.
[2] Kong X, Feng D, Wang H, et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology, 2012, 56: 1150-1159.
[3] Russ TC, Kivimäki M, Morling JR, et al. Association between psychological distress and liver disease mortality: a Meta-analysis of individual study participants. Gastro-enterology, 2015, 148: 958-966.
[4] Aghanwa HS, Ndubula D. Specfic psychiatric morbidity in liver cirrhosis in a Nigerian general hospital setting. Gen Hosp Psychiatry, 2002, 24: 436-441.
[5] Baldini S, Restani L, Baroncelli L, et al. Enriched early life experiences reduce adult anxiety-like behavior in rats: a role for insulin-like growth factor 1. J Neurosci, 2013, 33: 11715-11723.
[6] Su D, Zhang R, Zhang C, et al. Phenolic-rich lychee (Litchi chinensis Sonn.) pulp extracts offer hepatoprotection against restraint stress-induced liver injury in mice by modulating mitochondrial dysfunction. Food Funct, 2016, 7: 508-515.
[7] Jamal I, Kumar V, Vatsa N, et al. Environmental enrichment improves behavioral abnormalities in a mouse model of angelman syndrome. Mol Neurobiol, 2017, 54: 5319-5326.
[8] Song Y, Gan Y, Wang Q, et al. Enriching the housing environment for mice enhances their NK cell antitumor immunity via sympathetic nerve-dependent regulation of NKG2D and CCR5. Cancer Res, 2017, 77: 1611-1622.
[9] Dumoutier L, Van Roost E, Colau D, et al. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci U S A, 2000, 97: 10144-10149.
[10] Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity, 2007, 27: 647-659.
[11] Lu DH, Guo XY, Qin SY, et al. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines. World J Gastroenterol, 2015, 21: 1531-1545.
[12] Lai R, Xiang X, Mo R, et al. Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury. J Hepatol, 2015, 63: 148-155.
[13] Zhao D, Long XD, Lu TF, et al. Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma. Int J Cancer, 2015, 136: 2556-2565.
[14] Park O, Wang H, Weng H, et al. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology, 2011, 54: 252-261. |
